Inicio › Enfermedad de obstrucción pulmonar crónica › Texas

Ensayos clínicos de Enfermedad de obstrucción pulmonar crónica en Texas

25 estudios sobre Enfermedad de obstrucción pulmonar crónica buscan participantes en Texas.

Ciudades en Texas

Texto oficial del estudio (inglés)

A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis

Copd01 50001, Boerne

ReclutandoFase 2

Edades de 40 a 80 · Todos los sexos · Actualizado el 25 sept 2026 · NCT07725939

A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

Premier Pulmonary Critical Care and Sleep, Denison
Baylor College of Medicine Medical Center, Houston
Prime Clinical Research - Lewisville, Lewisville

ReclutandoFase 2

Edades de 40 a 75 · Todos los sexos · Actualizado el 25 sept 2026 · NCT07759245

A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.

REX Clinical Trials - Beaumont- Site Number : 8400011, Beaumont

ReclutandoFase 4

Edades de 40 a 85 · Todos los sexos · Actualizado el 22 sept 2026 · NCT07053423

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

Wellness Clinical Research - Allen- Site Number : 8400085, Allen
REX Clinical Trials - Beaumont- Site Number : 8400014, Beaumont
Novel Research - Bellaire- Site Number : 8400116, Bellaire
y 17 más

ReclutandoFase 3

Edades de 40 a 80 · Todos los sexos · Actualizado el 22 sept 2026 · NCT07190209

An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema

University of Texas Southwestern, Dallas

Reclutando

Edades de 40 a 80 · Todos los sexos · Actualizado el 17 sept 2026 · NCT06035120

A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)

WB Contracted Clinical Research Site, McKinney
WB Contracted Clinical Research Site, Waxahachie

ReclutandoFase 2

Edades de 40 a 80 · Todos los sexos · Actualizado el 15 sept 2026 · NCT07646587

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

IntraCare- Site Number : 8400034, Dallas
Premier Pulmonary Critical Care and Sleep- Site Number : 8400111, Denison
El Paso Pulmonary Association- Site Number : 8400033, El Paso
y 5 más

ReclutandoFase 3

Edades de 40 a 80 · Todos los sexos · Actualizado el 15 sept 2026 · NCT07190222

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Research Site, Boerne
Research Site, Dallas
Research Site, Denison
y 5 más

ReclutandoFase 2

Edades de 40 en adelante · Todos los sexos · Actualizado el 9 sept 2026 · NCT07082738

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

Baylor College of Medicine, Houston

ReclutandoFase 2

Edades de 40 en adelante · Todos los sexos · Actualizado el 4 sept 2026 · NCT07059091

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

Research Site, Boerne
Research Site, El Paso
Research Site, Houston
y 6 más

ReclutandoFase 3

Edades de 40 a 80 · Todos los sexos · Actualizado el 3 sept 2026 · NCT06878261

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

Research Site, Dallas
Research Site, Forney
Research Site, Fort Worth
y 5 más

ReclutandoFase 3

Edades de 40 a 80 · Todos los sexos · Actualizado el 3 sept 2026 · NCT06883305

The Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated With Dupilumab (STRIDE) Registry

The Lung & Sleep Institute of North Texas, North Richland Hills

ReclutandoEstudio observacional

Edades de 40 en adelante · Todos los sexos · Actualizado el 1 sept 2026 · NCT07612878

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

South Texas Medical Research Institute, Inc., DBA TTS Research, Boerne
Ten20 Clinical Research, Carrollton
Horizon Clinical Research Group, Cypress
y 4 más

ReclutandoFase 2/3

Edades de 35 a 80 · Todos los sexos · Actualizado el 31 ago 2026 · NCT07363694

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

Research Site, Abilene
Research Site, Brownsville
Research Site, Dallas
y 12 más

ReclutandoFase 3

Edades de 40 a 80 · Todos los sexos · Actualizado el 26 ago 2026 · NCT06283966

A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)

GC2501 Study Site 109, Dallas

ReclutandoFase 3

Edades de 18 a 80 · Todos los sexos · Actualizado el 11 ago 2026 · NCT07555483

To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment

Horizon Clinical Research Group., Cypress
DM Clinical Research- Tomball, Tomball

ReclutandoFase 2

Edades de 40 a 85 · Todos los sexos · Actualizado el 7 ago 2026 · NCT07684820

STRIVE Post-Market Registry Study

Baylor Scott & White Research Institute, Dallas
University of Texas Southwestern, Dallas
University of Texas Health Science Center at Houston, Houston

ReclutandoEstudio observacional

Edades de 18 en adelante · Todos los sexos · Actualizado el 3 ago 2026 · NCT04302272

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

GSK Investigational Site, Dallas
GSK Investigational Site, DeSoto
GSK Investigational Site, Greenville
y 6 más

ReclutandoFase 3

Edades de 40 a 75 · Todos los sexos · Actualizado el 28 jul 2026 · NCT07177339

Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer

Liver Center of Texas, Dallas
Methodist Hospital, Richardson

ReclutandoEstudio observacional

Edades de 18 en adelante · Todos los sexos · Actualizado el 10 jul 2026 · NCT05181826

Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3

Houston Methodist/Primary Critical Care, Houston

Reclutando

Edades de 40 a 84 · Todos los sexos · Actualizado el 24 abr 2026 · NCT06891755

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

GSK Investigational Site, Austin
GSK Investigational Site, Dallas
GSK Investigational Site, El Paso
y 5 más

ReclutandoFase 3

Edades de 40 a 80 · Todos los sexos · Actualizado el 9 abr 2026 · NCT06961214

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)

GSK Investigational Site, Corsicana

ReclutandoFase 3

Edades de 40 a 80 · Todos los sexos · Actualizado el 8 oct 2025 · NCT06959095

Interprofessional Pharmacogenomics (IPGx) Registry and Repository

Texas A&M Family Care, Bryan

ReclutandoEstudio observacional

Edades de 18 en adelante · Todos los sexos · Actualizado el 12 sept 2025 · NCT06726590

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

Horizon Clinical Research Group, Houston
CHRISTUS Trinity Mother Frances Health System, Tyler

ReclutandoEstudio observacional

Edades de 50 en adelante · Todos los sexos · Actualizado el 5 ago 2025 · NCT06122077

myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home

Respire Research Institute, Houston

Reclutando

Edades de 30 en adelante · Todos los sexos · Actualizado el 6 feb 2025 · NCT05204888

De ClinicalTrials.gov, datos obtenidos el 30 sept 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.